Courts hardens its stand on cross-pathy practice – Holds they are “quacks” who have “no respect for law and love for justice” Judgemment in favour of: Patient. 2 days ago Recommends that govt ban rampant prescription of allopathy drugs by doctors of other branches. While the practice of cross prescription of. The parliamentary panel on health wants the government to scrap its proposal for a bridge course to allow Ayush practitioners practice.

Author: Samulmaran Mirg
Country: Bhutan
Language: English (Spanish)
Genre: Marketing
Published (Last): 8 March 2010
Pages: 309
PDF File Size: 20.46 Mb
ePub File Size: 20.22 Mb
ISBN: 573-8-99058-893-2
Downloads: 19376
Price: Free* [*Free Regsitration Required]
Uploader: Gashakar

No ‘crosspathy’: House panel to oppose bridge course on allopathy for Ayush practitioners

Delhi Medical Council issues order against cross pathy. May 1 The Delhi Medical Council DMC recently issued an order warning registered doctors against the practice of cross pathy prescribing homoeopathy and ayurvedic drugs along with allopathy medicines. The order has come at the time when, according to DMC office bearers, the practice of cross prescription has become common among physicians.

The order issued by the registrar of DMC states that doctors pdactice with DMC are hereby directed not to practise or prescribe ayurvedic drugs. It says no cross pathy practise is allowed by any medical practitioner unless such person is also registered in that system in which he is practising. According to the order, drugs that are commonly prescribed include LIV52 and Amlycure DS for liver problems; Cystone for kidney stones; Septilin for better immunity; M2 Tone for polycystic ovarian disorder and other ovarian and fertility problems; Neeri for urinary problems and kidney stones; and Amycordial for womens health.

  D.S.0181 SABS PDF

The order also states that practising cross pathy can be punishable by rigorous imprisonment of up to three years and a fine of up to Rs 50, under the Delhi Bhartiya Chikitsa Parishad Act of Dr Anil Bansal, chairperson of the anti-quackery cell of DMC, said, It has become increasingly common for general practitioners and specialists in several established hospitals to prescribe ayurvedic drugs as an adjuvant to improve the efficacy of allopathic drugs.

The practice began with prescription of drugs to boost immunity for people suffering from respiratory infections or those prone to frequent seasonal virals.

Delhi Medical Council issues order against cross pathy | Cities News, The Indian Express

But the practice has swept across several specialised disciplines, including liver and kidney diseases and gynaecology. Doctors said the trend could have been fuelled by several drug companies entering the market in the past few years. A senior gastroenterologist in Delhi said, LIV52 is prescribed routinely to patients with hepatic disorders because it provides a long-term efficacy to allopathic drugs and boosts their outcome.


Crosepathy international studies have also established this and practitioners are using it abroad. It is crospathy available over the counter, so I do not understand the need for such orders.

Besides, we dont prescribe ayurvedic drugs as standalone options. Dr Bansal said while the efficacy of ayurvedic praactice homeopathic drugs in boosting the effect of other drugs was debatable, not many doctors are aware that cross pathy could lead to criminal proceedings. Just as prachice Medical Council of India Act prohibits specialists from traditional systems of medicine to practise allopathic drugs, the Delhi Bhartiya Chikitsa Parishad Act bans doctors with degrees in modern medicine to prescribe traditional drugs, he said.

Section 30 of the Act states that false assumption of medical practitioner under this Act to be an offence. Any person who falsely improves that he is a practitioner as defined in clause k of section 2 and practises Bhartiya Chikitsa Indian System of Medicineshall be punishable with rigorous imprisonment of up to three years and a fine of up to Rs 50, Post by The Financial Express.